We Are Building a Future Free of Age-Related Disease

SENS Research Foundation works to develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time. We are redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists.

Discover the science behind our strategies to extend a healthy lifespan.

Training a new generation of scientists to tackle the roots of age-related disease.

Keep up to date on SRF’s latest news and activities.

Outreach Highlights -

With the Sponsor a Student program, SENS Research Foundation is transforming young lives while revolutionizing aging research.

SRF is offering the opportunity to sponsor a PhD, Masters, Post-Baccalaureate, or a Summer student with a number of perks to accompany each donation!

You can give a deserving student the opportunity to conduct world-class research, learn more about the career that awaits them, and empower new allies in the fight against the diseases of aging.

Join us September 21st – 22nd, 2023, 9 am – 1 pm Pacific Time.

The forum will feature presentations from SRF’s intramural and extramural researchers, as well as our students.

This special interactive event will take place on a virtual-reality platform (https://meetaverse.com/) using the latest technology in online VR platforms.

You will not need a VR headset or to download any software. Details about the program, how to register, and join the platform will come soon.

Stay tuned and save these two days to attend!

Research Highlights -

Repairing the Extracellular Matrix:  Request for Proposal

The SENS Research Foundation is seeking proposals for innovative approaches to repairing age-related extracellular damage. Proposals should include a comprehensive description of the proposed approach and any supporting evidence, as well as a detailed budget and timeline for completion.

Education Highlights -

We say goodbye to our summer scholars, welcome our Post-Baccalaureate Fellows starting this month, and congratulate the winners of the Speed Presentations!

Announcing the launch of SRF’s Sponsor a Student Program – offering the opportunity to sponsor a PhD, Masters, postbaccalaureate, or a summer student with a number of perks to accompany each donation.

And proudly announcing the the launch of a Joint PhD Program between SENS Research Foundation and the University of Toledo Biological Sciences Department – offering a unique opportunity for aspiring researchers to pursue their doctoral degree in the cutting-edge field of anti-aging research, with a damage-repair approach.

Dr. Khalid Shah recently presented to SRF’s Education Department and team. His presentation, The Concept of Innovation and Orchestration: Translating Engineered Cellular Therapies for Cancer, introduces ideas for integrating different scientific disciplines to ultimately find a cure for cancer.

Dr. Shah is Principal Faculty at the Harvard Stem Cell Institute. Additionally, Dr. Shah is a Professor at Harvard Medical School, Vice Chair of Research at Brigham and Women’s Hospital Harvard Medical School, Founder/Director of the Center for Stem Cell and Translational Immunotherapy, and Founder/Director of the Center for Excellence in Biomedicine.


More Studies on Metformin and Survival

In this update, we review two recent papers that address the question of people with type 2 diabetes who take metformin living longer than people without the disease who don’t, but without the flaw in the 2014 study. We find that, as expected, metformin is a good diabetes drug but shows no sign of being a longevity therapeutic.

Sponsor a Student

SENS Research Foundation (SRF) is launching its campaign Sponsor a Student to increase charitable donations that will allow it to hire more student researchers and teach them that aging is not indisputable. Sponsoring a student dramatically transforms a young person’s life, giving them a chance to conduct world-class research and learn more about the career that awaits them.

Set My Heart Free: Two AmyloSENS Therapies Targeting Cardiac Amyloid in Clinical Trials

TTR cardiac amyloid contributes to heart failure and appears to limit the lives of the longest-lived humans. One AmyloSENS antibody shows high promise to remove this amyloid and restore function in the aging heart in an early-stage clinical trial. A second such antibody is coming close behind it, and a tiny number of people’s immune systems appear to generate such antibodies on their own.

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2023 SENS Research Foundation – ALL RIGHTS RESERVED

Thank you for Subscribing to the SENS Research Foundation Newsletter.

You can also


You can